Tissue-specific effects on uptake of 99mTc-sestamibi by breast lesions: a targeted analysis of false scintigraphic

Reinhold Tiling1, Katrin Stephan, Harald Sommer

  • 1Department of Nuclear Medicine, Innenstadt Ludwig-Maximilians-University of Munich, D-81377 Munich, Germany. reinhold.tiling@med.uni-muenchen.de

Abstract

Insights

Tumor size and tissue characteristics significantly impact technetium Tc 99m sestamibi uptake in breast lesions. Factors like inflammation and cellular density influence scintimammography accuracy for detecting small carcinomas.

Area of Science:

  • Nuclear medicine imaging
  • Oncology
  • Pathology

Background:

  • Scintimammography's sensitivity for small carcinomas is limited by gamma-camera resolution.
  • Technetium Tc 99m sestamibi uptake is a key factor in scintimammography.
  • Understanding factors affecting sestamibi uptake is crucial for improving breast cancer diagnosis.

Purpose of the Study:

  • To investigate tissue-specific parameters influencing technetium Tc 99m sestamibi uptake in breast lesions.
  • To determine if factors beyond tumor size affect sestamibi uptake in scintimammography.
  • To identify potential reasons for false-negative and false-positive scintigraphic findings.

Main Methods:

  • Histopathologic and immunohistochemical reevaluation of 75 surgical specimens (30 benign, 45 carcinomas).
  • Visual scoring of tissue parameters: lesion size, cellular density, vascularity, inflammation, proliferation, multidrug resistance, and receptor status.
  • Correlation of scored parameters with technetium Tc 99m sestamibi uptake on scintimammograms.

Main Results:

  • A strong correlation between sestamibi uptake and tumor size was observed.
  • Lesions <1 cm diameter were associated with false-negative diagnoses.
  • Low cellularity, low vascularity, and absence of inflammation negatively impacted sestamibi uptake in carcinomas.
  • Inflammatory changes were the primary driver of increased sestamibi uptake in benign lesions.
  • No correlation found with proliferative activity, multidrug resistance, or receptor status.

Conclusions:

  • Tumor size is a significant determinant of technetium Tc 99m sestamibi uptake.
  • Tissue parameters such as cellularity, vascularity, and inflammation interact to influence sestamibi uptake.
  • These findings suggest a multifactorial basis for sestamibi uptake in breast lesions, impacting scintimammography accuracy.